Academic Journal

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood

التفاصيل البيبلوغرافية
العنوان: Efficient mutation screening for cervical cancers from circulating tumor DNA in blood
المؤلفون: Lee, Sun-Young, Chae, Dong-Kyu, Lee, Sung-Hun, Lim, Yohan, An, Jahyun, Chae, Chang Hoon, Kim, Byung Chul, Bhak, Jong, Bolser, Dan, Cho, Dong-Hyu
المساهمون: Nation Research Foundation, Korea Industrial Technology Association, Ul­san Research Fund of UNIST, Ulsan Research Fund of UNIST
المصدر: BMC Cancer ; volume 20, issue 1 ; ISSN 1471-2407
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2020
الوصف: Background Early diagnosis and continuous monitoring are necessary for an efficient management of cervical cancers (CC). Liquid biopsy, such as detecting circulating tumor DNA (ctDNA) from blood, is a simple, non-invasive method for testing and monitoring cancer markers. However, tumor-specific alterations in ctDNA have not been extensively investigated or compared to other circulating biomarkers in the diagnosis and monitoring of the CC. Therfore, Next-generation sequencing (NGS) analysis with blood samples can be a new approach for highly accurate diagnosis and monitoring of the CC. Method Using a bioinformatics approach, we designed a panel of 24 genes associated with CC to detect and characterize patterns of somatic single-nucleotide variations, indels, and copy number variations. Our NGS CC panel covers most of the genes in The Cancer Genome Atlas (TCGA) as well as additional cancer driver and tumor suppressor genes. We profiled the variants in ctDNA from 24 CC patients who were being treated with systemic chemotherapy and local radiotherapy at the Jeonbuk National University Hospital, Korea. Result Eighteen out of 24 genes in our NGS CC panel had mutations across the 24 CC patients, including somatic alterations of mutated genes ( ZFHX3– 83%, KMT2C- 79% , KMT2D- 79%, NSD1–67%, ATM- 38% and RNF213 –27%). We demonstrated that the RNF213 mutation could be used potentially used as a monitoring marker for response to chemo- and radiotherapy. Conclusion We developed our NGS CC panel and demostrated that our NGS panel can be useful for the diagnosis and monitoring of the CC, since the panel detected the common somatic variations in CC patients and we observed how these genetic variations change according to the treatment pattern of the patient.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1186/s12885-020-07161-0
DOI: 10.1186/s12885-020-07161-0.pdf
DOI: 10.1186/s12885-020-07161-0/fulltext.html
الاتاحة: http://dx.doi.org/10.1186/s12885-020-07161-0
https://link.springer.com/content/pdf/10.1186/s12885-020-07161-0.pdf
https://link.springer.com/article/10.1186/s12885-020-07161-0/fulltext.html
Rights: https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.D0A5C794
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.D0A5C794
905
3
Academic Journal
academicJournal
905.017944335938
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.D0A5C794&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => http://dx.doi.org/10.1186/s12885-020-07161-0# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Efficient mutation screening for cervical cancers from circulating tumor DNA in blood )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Lee%2C+Sun-Young%22">Lee, Sun-Young</searchLink><br /><searchLink fieldCode="AR" term="%22Chae%2C+Dong-Kyu%22">Chae, Dong-Kyu</searchLink><br /><searchLink fieldCode="AR" term="%22Lee%2C+Sung-Hun%22">Lee, Sung-Hun</searchLink><br /><searchLink fieldCode="AR" term="%22Lim%2C+Yohan%22">Lim, Yohan</searchLink><br /><searchLink fieldCode="AR" term="%22An%2C+Jahyun%22">An, Jahyun</searchLink><br /><searchLink fieldCode="AR" term="%22Chae%2C+Chang+Hoon%22">Chae, Chang Hoon</searchLink><br /><searchLink fieldCode="AR" term="%22Kim%2C+Byung+Chul%22">Kim, Byung Chul</searchLink><br /><searchLink fieldCode="AR" term="%22Bhak%2C+Jong%22">Bhak, Jong</searchLink><br /><searchLink fieldCode="AR" term="%22Bolser%2C+Dan%22">Bolser, Dan</searchLink><br /><searchLink fieldCode="AR" term="%22Cho%2C+Dong-Hyu%22">Cho, Dong-Hyu</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Nation Research Foundation<br />Korea Industrial Technology Association<br />Ul­san Research Fund of UNIST<br />Ulsan Research Fund of UNIST )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => BMC Cancer ; volume 20, issue 1 ; ISSN 1471-2407 )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Springer Science and Business Media LLC )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2020 )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background Early diagnosis and continuous monitoring are necessary for an efficient management of cervical cancers (CC). Liquid biopsy, such as detecting circulating tumor DNA (ctDNA) from blood, is a simple, non-invasive method for testing and monitoring cancer markers. However, tumor-specific alterations in ctDNA have not been extensively investigated or compared to other circulating biomarkers in the diagnosis and monitoring of the CC. Therfore, Next-generation sequencing (NGS) analysis with blood samples can be a new approach for highly accurate diagnosis and monitoring of the CC. Method Using a bioinformatics approach, we designed a panel of 24 genes associated with CC to detect and characterize patterns of somatic single-nucleotide variations, indels, and copy number variations. Our NGS CC panel covers most of the genes in The Cancer Genome Atlas (TCGA) as well as additional cancer driver and tumor suppressor genes. We profiled the variants in ctDNA from 24 CC patients who were being treated with systemic chemotherapy and local radiotherapy at the Jeonbuk National University Hospital, Korea. Result Eighteen out of 24 genes in our NGS CC panel had mutations across the 24 CC patients, including somatic alterations of mutated genes ( ZFHX3– 83%, KMT2C- 79% , KMT2D- 79%, NSD1–67%, ATM- 38% and RNF213 –27%). We demonstrated that the RNF213 mutation could be used potentially used as a monitoring marker for response to chemo- and radiotherapy. Conclusion We developed our NGS CC panel and demostrated that our NGS panel can be useful for the diagnosis and monitoring of the CC, since the panel detected the common somatic variations in CC patients and we observed how these genetic variations change according to the treatment pattern of the patient. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1186/s12885-020-07161-0 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1186/s12885-020-07161-0.pdf )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1186/s12885-020-07161-0/fulltext.html )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://dx.doi.org/10.1186/s12885-020-07161-0<br />https://link.springer.com/content/pdf/10.1186/s12885-020-07161-0.pdf<br />https://link.springer.com/article/10.1186/s12885-020-07161-0/fulltext.html )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.D0A5C794 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1186/s12885-020-07161-0 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Efficient mutation screening for cervical cancers from circulating tumor DNA in blood [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lee, Sun-Young ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chae, Dong-Kyu ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lee, Sung-Hun ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lim, Yohan ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => An, Jahyun ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chae, Chang Hoon ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kim, Byung Chul ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bhak, Jong ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bolser, Dan ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Cho, Dong-Hyu ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Nation Research Foundation ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Korea Industrial Technology Association ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ul­san Research Fund of UNIST ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ulsan Research Fund of UNIST ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2020 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => BMC Cancer ; volume 20, issue 1 ; ISSN 1471-2407 [Type] => main ) ) ) ) ) ) )
IllustrationInfo